THE ROLE OF BIOTECHNOLOGY IN PERSONALIZED MEDICINE: TAILORING TREATMENTS THROUGH GENOMIC INSIGHTS

Abstract

With the introduction of personalized medicine, the conventional healthcare paradigm has changed in that instead of adhering to generalized treatment approach, a new healthcare paradigm now focuses on individualized treatment strategies. The centerpiece of this shift has been the inclusion of biotechnology that allows customizing medical interventions in accordance with the genetic, molecular, and phenotypic setups of a patient. This paper is going to discuss the crosshairs of a multidimensional role that Biotechnology can play towards the development of personalized medicine with attention paid to major areas including genomics, gene editing technologies, the identification of biomarkers, as well as the development of biopharmaceuticals.The study evaluates the recent cases of clinical application and case studies using mixed method of analysis in the areas of oncology, cardiovascular disease and genetic disorders. The methodology focused on such gene-editing tools as CRISPR-Cas9, genome sequencing systems, stem cell treatments, and AI-driven predictive models to evaluate their roles in the customization of treatment.The findings indicate higher accuracies in diagnosis, viability to predict treatment and the precision of treatment among different types of diseases. The editing of genes proved to be highly successful when it comes to correcting the mutations that already exist and are passed on to the next generations, and stem cell therapy produced positive results in regard to regeneration in neurodegenerative and cardiovascular diseases. Pharmacogenomic profiling through biomarker-directed use of drugs augmented the therapeutic potential of treatment regimen, and liquid biopsy methods allowed monitoring disease progress in real-time.Notwithstanding these developments, there are still challenges such as moral issues relating to gene manipulation, expensive nature of the therapies or treatments that could be customized to depend on the individual, and the necessity of strict protection of data relating to it. The study came to the conclusion that although biotechnology has opened the new horizons in the field of personalized medicine, further success of it depends on the topics of equal access to it, effective regulation and cooperation. Possession of ongoing innovation and ethical monitoring, biotechnology-based personalized medicine will have the ability to restructure future of patient-based care.